Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
161.6 USD | +3.31% | +6.19% | -15.64% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.64% | 19.79B | |
+50.18% | 56.87B | |
+37.15% | 39.72B | |
-5.91% | 39.27B | |
-6.90% | 28.73B | |
+13.17% | 26.21B | |
+31.25% | 12.28B | |
+28.09% | 12.23B | |
+0.58% | 12.12B | |
-8.83% | 10.84B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals Says Phase 2 Study of Hypertension Drug Zilebesiran Meets Primary Endpoint